Mesna Injection Shortage

• • Mesna solution for injection, Mylan Institutional, 100 mg/mL, 10 mL vial, 10 count, NDC 67457-0148-10

• • Fresenius Kabi had mesna on shortage due to increased demand.
  • Mylan could not provide a reason for the shortage.
  • Sagent had mesna on shortage due to manufacturing delays.
  • Teva had a shortage of mesna injection due to manufacturing delays.
  • West-Ward discontinued mesna injection in September 2014.

• • Mesnex solution for injection, Baxter, 100 mg/mL, 10 mL vial, 1 count, NDC 00338-1305-01
  • Mesnex solution for injection, Baxter, 100 mg/mL, 10 mL vial, 10 count, NDC 00338-1305-03
  • Mesna solution for injection, Baxter, 100 mg/mL, 10 mL vial, 1 count, NDC 10019-0953-01
  • Mesna solution for injection, Baxter, 100 mg/mL, 10 mL vial, 10 count, NDC 10019-0953-02
  • Mesna solution for injection, Fresenius Kabi, 100 mg/mL, 10 mL vial, 1 count, NDC 63323-0733-11
  • Mesna solution for injection, Fresenius Kabi, 100 mg/mL, 10 mL vial, 10 count, NDC 63323-0733-10
  • Mesna solution for injection, Sagent, 100 mg/mL, 10 mL vial, 1 count, NDC 25021-0201-10
  • Mesna solution for injection, Sagent, 100 mg/mL, 10 mL vial, 10 count, NDC 25021-0201-11
  • Mesna solution for injection, Teva, 100 mg/mL, 10 mL vial, 10 count, NDC 00703-4805-03

Estimated Resupply Dates

• • Mylan Institutional has mesna 10 mL vials on back order and the company cannot estimate a release date.
  • All other marketed suppliers have product available.